tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AKRO Stock Latest News

Class Action Lawsuit against Akero Therapeutics, Inc. (NASDAQ:AKRO)
Market NewsClass Action Lawsuit against Akero Therapeutics, Inc. (NASDAQ:AKRO)
1M ago
AKRO
Akero Therapeutics Announces Initiation of Phase 3 SYNCHRONY Outcomes Trial of Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
PremiumPress Releases
Akero Therapeutics Announces Initiation of Phase 3 SYNCHRONY Outcomes Trial of Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
1M ago
AKRO
Akero Therapeutics announces initiation of Phase 3 SYNCHRONY outcomes trial
PremiumThe Fly
Akero Therapeutics announces initiation of Phase 3 SYNCHRONY outcomes trial
1M ago
AKRO
Akero Therapeutics initiated with an Outperform at Wolfe Research
PremiumThe Fly
Akero Therapeutics initiated with an Outperform at Wolfe Research
1M ago
AKRO
MDGL
Madrigal Pharmaceuticals initiated with an Outperform at Wolfe Research
PremiumThe Fly
Madrigal Pharmaceuticals initiated with an Outperform at Wolfe Research
1M ago
AKRO
MDGL
Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024
PremiumPress ReleasesAkero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024
2M ago
AKRO
Madrigal, 89bio, Akero slip after Eli Lilly MASH data released
PremiumThe Fly
Madrigal, 89bio, Akero slip after Eli Lilly MASH data released
2M ago
LLY
AKRO
Akero Therapeutics price target lowered to $38 from $50 at Evercore ISI
PremiumThe Fly
Akero Therapeutics price target lowered to $38 from $50 at Evercore ISI
2M ago
AKRO
MDGL
Akero Therapeutics price target lowered to $56 from $59 at Canaccord
PremiumThe Fly
Akero Therapeutics price target lowered to $56 from $59 at Canaccord
2M ago
AKRO
Akero Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Akero Therapeutics files automatic mixed securities shelf
3M ago
AKRO
Akero Therapeutics reports Q1 EPS (90c), consensus (95c)
PremiumThe Fly
Akero Therapeutics reports Q1 EPS (90c), consensus (95c)
3M ago
AKRO
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
3M ago
AKRO
Akero Therapeutics appoints Gangloff as Chief Technology Officer
PremiumThe FlyAkero Therapeutics appoints Gangloff as Chief Technology Officer
3M ago
AKRO
Akero Therapeutics reinstated with a Neutral at BofA
PremiumThe Fly
Akero Therapeutics reinstated with a Neutral at BofA
3M ago
AKRO
JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
PremiumThe Fly
JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
5M ago
AKRO
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
PremiumPress Releases
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5M ago
AKRO
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
PremiumPress Releases
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
5M ago
AKRO
89bio price target raised to $37 from $29 at Evercore ISI
PremiumThe Fly
89bio price target raised to $37 from $29 at Evercore ISI
5M ago
AKRO
ETNB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
AKRO
BBIO
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
PremiumPress ReleasesAkero Therapeutics Announces Pricing of Public Offering of Common Stock
5M ago
AKRO
Akero Therapeutics 11M share Secondary priced at $29.00
PremiumThe Fly
Akero Therapeutics 11M share Secondary priced at $29.00
5M ago
AKRO
Akero Therapeutics price target raised to $50 from $43 at H.C. Wainwright
PremiumThe Fly
Akero Therapeutics price target raised to $50 from $43 at H.C. Wainwright
5M ago
AKRO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >